Stock comparison
Eli Lilly
STERIS
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
LLY
Eli Lilly
Market cap
$1T
Sector
Healthcare
STE
STERIS
Market cap
$21.26B
Sector
Healthcare
Overall winner
Eli Lilly LLY
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | LLY | STE | Winner |
|---|---|---|---|
| Warren Buffett | 72B | 53C | LLY |
| Benjamin Graham | 86A | 68B | LLY |
| Philip Fisher | 86A | 58C | LLY |
| Peter Lynch | 74B | 52C | LLY |
| Joel Greenblatt | 78C | 35D | LLY |
| Charlie Munger | 85A | 42D | LLY |
| Terry Smith | 77C | 48D | LLY |
Side-by-side metrics
| Metric | LLY | STE |
|---|---|---|
| Market cap | $1T | $21.26B |
| P/E (TTM) | 36.6x | 25.3x |
| EV/EBIT | 34.1x | 17.7x |
| ROIC (TTM) | 32.06% | 8.51% |
| Gross margin | 83.51% | 44.25% |
| Net margin | 34.98% | 13.18% |
| Revenue CAGR 5y | 23.17% | 8.88% |
| EPS CAGR 5y | 40.81% | 33.45% |
| Debt / Equity | 1.4x | 0.0x |
| Dividend yield | 0.62% | 1.22% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
LLY leads on
- Market cap$1Tvs $21.26B+98%
- ROIC (TTM)32.06%vs 8.51%+73%
- Net margin34.98%vs 13.18%+62%
- Revenue CAGR 5y23.17%vs 8.88%+62%
STE leads on
- Debt / Equity0.0xvs 1.4x+99%
- Dividend yield1.22%vs 0.62%+49%
- EV/EBIT17.7xvs 34.1x+48%
- P/E (TTM)25.3xvs 36.6x+31%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.